Lumos Pharma | 4:持股變動聲明-高管 Schuchart Aaron
Lumos Pharma | 4:持股變動聲明-高管 Hawkins Richard J
Lumos Pharma | 4:持股變動聲明-高管 McKew John C.
Lumos Pharma | 4:持股變動聲明-高管 POWERS BRADLEY J
Lumos Pharma | 4:持股變動聲明-高管 Lawley Lori D
Lumos Pharma | 4:持股變動聲明-高管 Pitukcheewanont Pisit Duke
Lumos Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(5.1 %),GOLDMAN SACHS & CO. LLC(5.1 %)
Lumos Pharma | 4:持股變動聲明-高管 McKew John C.
Lumos Pharma | SC 13G:超過5%持股股東披露文件-Wells Fargo & Company (b) Tax ID(5.3%)
Lumos Pharma | 4:持股變動聲明-高管 McKew John C.
Lumos Pharma | 4:持股變動聲明-高管 Hawkins Richard J
Lumos Pharma | 4:持股變動聲明-高管 Lawley Lori D
Lumos Pharma | 4:持股變動聲明-高管 Schuchart Aaron
Lumos Pharma | 4:持股變動聲明-高管 POWERS BRADLEY J
Lumos Pharma | 3:首次持股聲明-高管 Pitukcheewanont Pisit Duke
Lumos Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-Clarus Lifesciences III, L.P.(4.9%),Clarus Ventures III GP, L.P.(4.9%)等
Lumos Pharma | 4:持股變動聲明-高管 McKew John C.
Lumos Pharma | 4:持股變動聲明-首席財務官 Lawley Lori D
Lumos Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-Daniel Farb(4.90%)
Lumos Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-Daniel Farb(6.08%)
暫無數據